CEO of Indian pharma company Dr Reddy's has warned that Trump's proposed tariffs on generic drugs will make them more expensive for patients.

While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the…

Trump has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.

Trump announces a tariff timeline for generic drugs, starting with zero tariffs for a year, then escalating to 200%.

Pharma stocks fall as Aurobindo Pharma drops over 4% following Trump's tariff announcement on imported generic medicines.

President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028, rising to 200% a year later. The move…

US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical exporters, but the country's cost advantage…